— Know what they know.
Not Investment Advice
Also trades as: YPSN.SW (SIX) · $vol 6M · 0QLQ.L (LSE) · $vol 1M

YPHDF OTC

Ypsomed Holding AG
1W: +0.0% 1M: -12.9% 3M: +2.6% YTD: +11.4% 1Y: -8.1% 3Y: +194.2%
$436.55
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Sell · Power 42 · $5.7B mcap · 4M float · 0.0000% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$307M +107.0% ▲
5Y CAGR: +29.0%
Capital Expenditures
$323M -16.6% ▼
5Y CAGR: +20.6%
Free Cash Flow
-$16M +87.3% ▲
Dividends Paid
$30M -10.0% ▼
Buybacks
$151M -5859.0% ▼
Net Change in Cash
-$8M +78.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$23M$51M$78M$88M$222M
Depreciation & Amort.$68M$79M$75M$80M$82M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$7M$11M-$46M-$66M$51M
Other Non-Cash Items$2M-$11M$56M$47M-$48M
Operating Cash Flow$86M$130M$163M$148M$307M
— Investing Activities —
Capital Expenditures-$127M-$169M-$116M-$206M-$296M
Acquisitions (Net)-$1M$46M$0$8M$305M
Investment Purchases$74M-$46M$0$0-$10M
Investment Sales$3M$46M$0$0$0
Other Investing-$74M$845K-$79M-$70M-$27M
Investing Cash Flow-$126M-$122M-$195M-$267M-$27M
— Financing Activities —
Net Debt Issuance$52M-$25M$99M$111M-$106M
Stock Repurchased-$263K-$2M-$1M-$3M-$151M
Dividends Paid-$15M-$8M-$18M-$27M-$30M
Other Financing$1M$0$1K-$1K$1K
Financing Cash Flow$38M$1M$81M$82M-$286M
Net Change in Cash-$2M$9M$49M-$38M-$8M
Cash End of Period$16M$24M$74M$36M$29M
Free Cash Flow-$42M-$40M-$32M-$129M-$16M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms